Divis Laboratories Ltd reported INR110.96B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Aurobindo Pharma INR 327.09B 40.6B Mar/2026
Avita Medical AUD 35.49M 760K Dec/2025
Dianthus Therapeutics USD 1.12B 710.47M Mar/2026
Divis Laboratories Ltd INR 110.96B 12.53B Mar/2026
Ionis Pharmaceuticals USD 2.94B 52M Mar/2026
IQVIA Holdings USD 6.22B 29M Mar/2026
Lupin INR 240.27B 37.61B Mar/2026
Moderna USD 5.77B 774M Mar/2026
Organon & Co USD 4.93B 580M Mar/2026
Revvity USD 2.13B 111.43M Mar/2026
Tectonic Therapeutic USD 239.89M 17.47M Mar/2026
Tilray USD 729.32M 28.18M Sep/2025
Viatris USD 10.92B 1.13B Mar/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026